Senti Biosciences (SNTI) Change in Account Payables (2021 - 2025)
Senti Biosciences' quarterly Change in Account Payables came in at $1.2 million in Q4 2025, down 5.33% year-on-year from $1.2 million in Q4 2024, and up 56.4% quarter-over-quarter from $750000.0 in Q3 2025.
Senti Biosciences has reported Change in Account Payables for 5 years, with the latest figure at $1.2 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables fell 5.33% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (up 118.7% YoY), and the FY2025 full-year result was $1.7 million, up 118.7% from the prior year.
- Change in Account Payables for Q4 2025 stood at $1.2 million, up from $750000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.2 million in Q4 2024, with the low at -$2.3 million in Q4 2021.
- Average Change in Account Payables over 5 years is $5381.3, with a median of $2299.0 recorded in 2021.
- Peak annual rise in Change in Account Payables reached 8718.97% in 2022, while the deepest fall reached 585814.29% in 2022.
- Tracing SNTI's Change in Account Payables over 5 years: stood at -$2.3 million in 2021, then soared by 103.99% to $93000.0 in 2022, then sank by 911.83% to -$755000.0 in 2023, then jumped by 264.11% to $1.2 million in 2024, then decreased by 5.33% to $1.2 million in 2025.
- The last three Change in Account Payables figures came in at $1.2 million (Q4 2025), $750000.0 (Q3 2025), and -$537000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.17 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 750,000.00 |
| Sep 30, 2025 | 750,000.00 |
| Jun 30, 2025 | -537,000.00 |
| Jun 30, 2025 | -537,000.00 |
| Mar 31, 2025 | 357,000.00 |
| Mar 31, 2025 | 357,000.00 |
| Dec 31, 2024 | 1.24 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | -388,000.00 |
| Sep 30, 2024 | -388,000.00 |
| Jun 30, 2024 | -443,000.00 |
| Jun 30, 2024 | -443,000.00 |
| Mar 31, 2024 | 389,000.00 |
| Mar 31, 2024 | 389,000.00 |
| Dec 31, 2023 | -755,000.00 |
| Dec 31, 2023 | -755,000.00 |
| Sep 30, 2023 | -420,000.00 |
| Sep 30, 2023 | -420,000.00 |
| Jun 30, 2023 | 605,000.00 |
| Jun 30, 2023 | 605,000.00 |
| Mar 31, 2023 | 280,000.00 |
| Mar 31, 2023 | 280,000.00 |
| Dec 31, 2022 | 93,000.00 |
| Dec 31, 2022 | 93,000.00 |
| Sep 30, 2022 | -141,000.00 |
| Sep 30, 2022 | -141,000.00 |
| Jun 30, 2022 | 398,000.00 |
| Jun 30, 2022 | 398,000.00 |
| Mar 31, 2022 | -164,000.00 |
| Mar 31, 2022 | -164,000.00 |
| Dec 31, 2021 | -2.33 Mn |
| Dec 31, 2021 | -2.33 Mn |
| Sep 30, 2021 | 85.00 |
| Sep 30, 2021 | 85.00 |
| Jun 30, 2021 | 4,513.00 |
| Jun 30, 2021 | 4,513.00 |
| Mar 31, 2021 | 28.00 |
| Mar 31, 2021 | 28.00 |